Church & Dwight Co. Earnings Call Transcripts
Fiscal Year 2026
-
Consistent category outperformance, portfolio reshaping, and innovation fueled strong 2025 results and set the stage for 2026 growth. Key initiatives target ARM & HAMMER, TheraBreath, and international expansion, supported by robust cash flow and disciplined capital allocation.
Fiscal Year 2025
-
Q4 2025 sales grew 3.9% with strong contributions from Touchland and core brands, while portfolio reshaping and productivity drove gross margin and EPS gains. 2026 guidance calls for 3%-4% organic growth, 5%-8% EPS growth, and continued focus on innovation, international expansion, and disciplined capital allocation.
-
Q3 results exceeded expectations with 3.4% organic sales growth and strong EPS. Touchland acquisition outperformed, while value and premium brands drove share gains. Full-year guidance was raised for sales, EPS, and cash flow, with continued focus on M&A and innovation.
-
Confidence in future growth is driven by strong brand performance, innovation, and expanding international and e-commerce channels. Key brands like Arm & Hammer, Hero, and TheraBreath are gaining share, while new acquisitions and product launches fuel momentum. 2025 guidance targets up to 2% sales and EPS growth.
-
Organic sales and adjusted EPS exceeded expectations in Q2, driven by share gains in key brands and improved category consumption. The company closed the Touchland acquisition, exited several businesses, and is reviewing strategic options for its vitamin segment, while maintaining a cautious outlook amid ongoing macro volatility.
-
ARM & HAMMER and other power brands continue to gain share through innovation and a strong multi-category presence, with recent acquisitions like Touchland expected to drive further growth. International expansion, disciplined M&A, and robust online and specialty product performance support a positive 2025 outlook.
-
The acquisition of a leading, fast-growing hand sanitizer brand for up to $880 million is expected to be EPS-neutral in 2025 and 3% accretive to cash earnings in 2026. The deal leverages innovation, strong brand loyalty, and international expansion, with a focus on premium channels and significant runway for growth.
-
Organic sales declined 1.2% in Q1 2025 due to retail destocking and weak U.S. demand, prompting a revised full-year organic growth outlook of 0%-2% and adjusted EPS growth of 0%-2%. Strategic exits and supply chain actions are expected to reduce tariff exposure by 80%.
-
Leadership transition to Rick Dierker is underway, with a strong 2024 performance marked by 4.5% organic growth, robust cash flow, and gains in five of seven power brands. Innovation and international expansion remain key priorities, supported by a disciplined M&A strategy and a culture focused on execution and adaptability.
Fiscal Year 2024
-
2024 delivered strong organic growth, margin expansion, and record cash flow, with innovation and digital driving results. 2025 guidance calls for 3%-4% organic growth, continued margin gains, and robust M&A capacity, while inflation and category growth moderation remain key watchpoints.
-
Q3 results exceeded expectations with 3.8% reported and 4.3% organic sales growth, driven by strong performance across domestic, international, and specialty segments. Adjusted EPS and gross margin improved, but a $357 million impairment in the vitamin business impacted reported earnings. Cautious outlook for Q4 amid category growth volatility and increased promotional activity in litter.
-
Raised organic growth targets and maintained strong financial performance, with power brands and innovation driving share gains in both U.S. and international markets. E-commerce and M&A remain key priorities, while operational discipline and ESG commitments support long-term value.
-
Q2 delivered strong sales and EPS beats, with robust gross margin expansion and market share gains across most brands. Full-year guidance was tightened due to category deceleration, but innovation and international growth remain key strengths.
-
The company projects strong 2024 growth, driven by innovation, e-commerce, and disciplined M&A. U.S. and international businesses are both expanding, with key brands like TheraBreath and Hero gaining share. Focus areas include sustainability, digital marketing, and asset-light operations.